Cargando…

Parameters of Right Ventricle as etiological distinction between ischemic and non-ischemic dilated cardiomyopathy

Detalles Bibliográficos
Autores principales:	Gomes, Hélder Andrade, Lamacié, Mariana M, Fernandes, Fábio V, Abreu, Bernardo N, Freitas, Matheus D, Dias Filho, Paulo C, Moreira, Valéria, Carneiro, Adriano, Magalhães, Tiago A, Rochitte, Carlos E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328664/ http://dx.doi.org/10.1186/1532-429X-17-S1-P311

Ejemplares similares

Left ventricle morphological and functional characteristics associated to the presence and magnitude of myocardial fibrosis by CMR in hypertrophy cardiomiopathy
por: Gomes, Hélder Andrade, et al.
Publicado: (2014)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Left ventricle restoration in end stage ischemic dilated cardiomyopathy
por: Jonjev, Z
Publicado: (2013)

Different expression and prognostic value of troponin in ischemic cardiomyopathy and non-ischemic dilated cardiomyopathy
por: Gao, Wei, et al.
Publicado: (2023)

The Ubiquitin Proteasome System in Ischemic and Dilated Cardiomyopathy
por: Spänig, Sabine, et al.
Publicado: (2019)

Energy Metabolites as Biomarkers in Ischemic and Dilated Cardiomyopathy
por: Haas, Jan, et al.
Publicado: (2021)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

Mechanical effects of midwall fibrosis in non-ischemic dilated cardiomyopathy
por: Taylor, Robin J, et al.
Publicado: (2014)

Cardiac Proteome Profiling in Ischemic and Dilated Cardiomyopathy Mouse Models
por: Lu, Danbo, et al.
Publicado: (2019)

Comparison of periodontal parameters between patients with ischemic and dilative cardiomyopathy
por: Ziebolz, Dirk, et al.
Publicado: (2021)

Prognosis of Coronary Atherosclerotic Burden in Non-Ischemic Dilated Cardiomyopathies
por: Canu, Marjorie, et al.
Publicado: (2021)

Echocardiography-based machine learning algorithm for distinguishing ischemic cardiomyopathy from dilated cardiomyopathy
por: Zhou, Mei, et al.
Publicado: (2023)

Left Atrial Volume Determinants in Patients with Non-Ischemic Dilated Cardiomyopathy
por: Mancuso, Frederico José Neves, et al.
Publicado: (2015)

The circulating level of interleukins 6 and 18 in ischemic and idiopathic dilated cardiomyopathy
por: Iravani Saadi, Mahdiyar, et al.
Publicado: (2019)

Decreased eGFR Is Associated With Ischemic Stroke in Patients With Dilated Cardiomyopathy
por: Deng, Yuqing, et al.
Publicado: (2019)

Statistical suggestions for long-term outcomes for non-ischemic dilated cardiomyopathy
por: Agstam, Sourabh, et al.
Publicado: (2021)

Ischemic Cardiomyopathy versus Non-Ischemic Dilated Cardiomyopathy in Patients with Reduced Ejection Fraction— Clinical Characteristics and Prognosis Depending on Heart Failure Etiology (Data from European Society of Cardiology Heart Failure Registries)
por: Tymińska, Agata, et al.
Publicado: (2022)

Comparison of ventricular tachyarrhythmia recurrence between ischemic cardiomyopathy and dilated cardiomyopathy: a retrospective study
por: Fang, Chih-Yuan, et al.
Publicado: (2018)

Inflammatory dilated cardiomyopathy: Etiology and clinical management
por: Maisch, Bernhard, et al.
Publicado: (2020)

Silent cerebral infarction in chronic heart failure: Ischemic and nonischemic dilated cardiomyopathy
por: Kozdag, Guliz, et al.
Publicado: (2008)

Risk Stratification for Sudden Cardiac Death In Patients With Non-ischemic Dilated Cardiomyopathy
por: Shekha, Karthik, et al.
Publicado: (2005)

Long-Term Prognostic Value of Restitution Slope in Patients with Ischemic and Dilated Cardiomyopathies
por: Dorenkamp, Marc, et al.
Publicado: (2013)

The association between ECV and microcirculation perfusion abnormalities in non-ischemic dilated cardiomyopathy
por: Ali, Aamir, et al.
Publicado: (2014)

Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy
por: Tompkins, Bryon A., et al.
Publicado: (2018)

Statistical suggestions for long-term outcomes of non-ischemic dilated cardiomyopathy patients
por: Bursa, Nurbanu
Publicado: (2021)

Myostatin/AKT/FOXO Signaling Is Altered in Human Non-Ischemic Dilated Cardiomyopathy
por: Hildebrandt, Lea, et al.
Publicado: (2022)

Impact of implantable cardioverter defibrillator on survival in patients with non‐ischemic dilated cardiomyopathy
por: Kataoka, Naoya, et al.
Publicado: (2023)

Prognostic implication of liver fibrosis scores in patients with non-ischemic dilated cardiomyopathy
por: Liu, Yupeng, et al.
Publicado: (2023)

Integrative Proteomic Analysis Reveals the Cytoskeleton Regulation and Mitophagy Difference Between Ischemic Cardiomyopathy and Dilated Cardiomyopathy
por: Liu, Muyin, et al.
Publicado: (2023)

Association between Latest Activated Sites in the Left Ventricle and Akinetic Segments in Patients with Ischemic Cardiomyopathy
por: Sadeghian, Hakimeh, et al.
Publicado: (2016)

Sensitivity Analysis of Left Ventricle with Dilated Cardiomyopathy in Fluid Structure Simulation
por: Chan, Bee Ting, et al.
Publicado: (2013)

Circulating circRNA as biomarkers for dilated cardiomyopathy etiology
por: Costa, Marina C., et al.
Publicado: (2021)

Reverse Remodeling and Functional Improvement of Left Ventricle in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan: Comparison between Non-Ischemic and Ischemic Etiology
por: Cemin, Roberto, et al.
Publicado: (2023)

Impact of Shocks on Mortality in Patients with Ischemic or Dilated Cardiomyopathy and Defibrillators Implanted for Primary Prevention
por: Streitner, Florian, et al.
Publicado: (2013)

RNA Sequencing Analysis and Atrial Natriuretic Peptide Production in Patients with Dilated and Ischemic Cardiomyopathy
por: Tarazón, Estefanía, et al.
Publicado: (2014)

Native left ventricular myocardial T(1) spatial heterogeneity in non-ischemic dilated cardiomyopathy
por: Kashem, Abyaad, et al.
Publicado: (2016)

Post-transcriptional modifications of VEGF-A mRNA in non-ischemic dilated cardiomyopathy
por: Kowalczyk, Jacek, et al.
Publicado: (2007)

Nanoscale regulation of L-type calcium channels differentiates between ischemic and dilated cardiomyopathies.
por: Sanchez-Alonso, Jose L., et al.
Publicado: (2020)

NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy
por: Zeng, Cheng, et al.
Publicado: (2020)

Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy
por: Rieger, Angela C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9u3vc3ji88c8qtclkm6u2pntut